Clinical Trials Logo

Cocaine Abuse or Dependence clinical trials

View clinical trials related to Cocaine Abuse or Dependence.

Filter by:
  • None
  • Page 1

NCT ID: NCT01392092 Completed - Clinical trials for Cocaine Related Disorders

Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)

NAC
Start date: July 2011
Phase:
Study type: Observational

N-acetylcysteine (NAC) is a medication that the Food and Drug Administration (FDA) has approved for several medical uses, such as dissolving mucus in patients with breathing problems, treating overdose from acetaminophen (Tylenol), and protecting the kidneys from toxic substances. Some recent studies suggest that NAC could be useful in the treatment of other disorders including addictions. One purpose of this study is to determine whether NAC alters the level of brain glutamate (a chemical that excites brain cells). The other main purpose is to determine whether NAC affects how much cocaine people use.

NCT ID: NCT00946660 Completed - Clinical trials for Cocaine Related Disorders

Non-Treatment Study of Factors Affecting Cocaine Drug Choice

CTA
Start date: July 2009
Phase: N/A
Study type: Observational

This research deals with behaviors that are part of drug dependence. The purpose is to study how certain factors, including money, the amount of drug available, and the amount of work effort, affect cocaine drug choice. Specifically, we will examine the effects of two issues/factors. The first is how hard individuals are willing to work to obtain a drug; the second is how much drug would individuals choose instead of money, when the amount of probability of money is predictable or unpredictable.

NCT ID: NCT00698737 Completed - Clinical trials for Opioid-Related Disorders

Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)

ARC
Start date: April 2008
Phase: N/A
Study type: Observational

This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or dependence, and who may also have heroin dependence. The purpose of this study is to test whether oral sustained release d-amphetamine (SR-AMP) is safe and more effective than placebo for preventing relapse to cocaine use for individuals who abuse or are dependent upon cocaine. We are also interested whether, for patients who are dependent on cocaine and heroin, whether SR-AMP is safe and effective for preventing cocaine relapse in combination with buprenorphine.

NCT ID: NCT00429767 Completed - Clinical trials for Opioid-Related Disorders

Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals

Start date: January 2007
Phase: Phase 1
Study type: Observational

The purpose of this study is to determine whether maintenance on different oral doses of sustained release d-amphetamine (SR-AMP) combined with constant-dose sublingual buprenorphine (BUP) is safe and well tolerated and decreases self-administration of cocaine alone or combined with hydromorphone (HYD). Secondary aims are to determine whether SR-AMP attenuates the subjective and physiological effects of cocaine during drug sampling periods prior to choice opportunities.